Brokerages forecast that Sapiens International Co. (NASDAQ:SPNS) will report sales of $71.50 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Sapiens International’s earnings. The lowest sales estimate is $70.60 million and the highest is $72.40 million. Sapiens International posted sales of $57.11 million during the same quarter last year, which would indicate a positive year over year growth rate of 25.2%. The firm is scheduled to announce its next quarterly earnings results before the market opens on Tuesday, February 27th.
On average, analysts expect that Sapiens International will report full year sales of $71.50 million for the current fiscal year, with estimates ranging from $268.20 million to $272.00 million. For the next fiscal year, analysts forecast that the business will post sales of $281.44 million per share, with estimates ranging from $280.37 million to $282.50 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side analysts that follow Sapiens International.
Several brokerages recently weighed in on SPNS. Zacks Investment Research cut Sapiens International from a “hold” rating to a “sell” rating in a research note on Thursday, February 15th. BidaskClub raised Sapiens International from a “sell” rating to a “hold” rating in a research note on Friday, February 2nd. Finally, Barclays cut Sapiens International from an “overweight” rating to an “equal weight” rating in a research note on Friday. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $15.00.
Hedge funds have recently modified their holdings of the stock. Kingfisher Capital LLC purchased a new stake in Sapiens International in the fourth quarter worth $118,000. ARK Investment Management LLC purchased a new stake in Sapiens International in the fourth quarter worth $213,000. Jane Street Group LLC boosted its holdings in Sapiens International by 58.5% in the third quarter. Jane Street Group LLC now owns 25,690 shares of the technology company’s stock worth $339,000 after acquiring an additional 9,485 shares in the last quarter. Menora Mivtachim Holdings LTD. bought a new stake in Sapiens International in the third quarter worth $402,000. Finally, Dimensional Fund Advisors LP bought a new stake in Sapiens International in the second quarter worth $358,000. 8.44% of the stock is currently owned by institutional investors.
Shares of Sapiens International (SPNS) opened at $9.16 on Tuesday. The firm has a market capitalization of $450.81, a price-to-earnings ratio of 458.00, a P/E/G ratio of 4.41 and a beta of 0.98. Sapiens International has a 12 month low of $9.14 and a 12 month high of $15.46. The company has a quick ratio of 2.03, a current ratio of 2.03 and a debt-to-equity ratio of 0.39.
WARNING: This story was published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this story on another publication, it was stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this story can be read at https://www.thelincolnianonline.com/2018/03/14/71-50-million-in-sales-expected-for-sapiens-international-co-spns-this-quarter.html.
Sapiens International Company Profile
Sapiens International Corporation N.V. (Sapiens) is a provider of software solutions for the insurance industry, with a focus on the financial services sector. The Company operates in provider of software solutions segment. Its software solutions portfolio consists of Life, Pension, Annuity and Retirement Solutions, including software solutions for the management of a range of products for life, pension, annuity and retirement; Property and Casualty/General Insurance Solutions, including a software suite of solutions, supporting a range of business lines, including personal, commercial and specialty lines, as well as a solution for the management of reinsurance contracts; Sapiens DECISION, which is a business decision management solution, and Technology-Based Solutions, such as Sapiens eMerge.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sapiens International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sapiens International and related companies with MarketBeat.com's FREE daily email newsletter.